Intravenous isavuconazole can be administered 5 days-a-week. A possibility suggested by a real-life observation.
Administration, Intravenous
Antifungal Agents
/ administration & dosage
Aspergillosis
/ complications
Child
Drug Monitoring
Humans
Male
Nitriles
/ administration & dosage
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
/ complications
Pyridines
/ administration & dosage
Triazoles
/ administration & dosage
Isavuconazole
pediatrics intermittent therapy
plasma concentrations
Journal
Journal of chemotherapy (Florence, Italy)
ISSN: 1973-9478
Titre abrégé: J Chemother
Pays: England
ID NLM: 8907348
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
pubmed:
5
5
2020
medline:
29
4
2021
entrez:
5
5
2020
Statut:
ppublish
Résumé
In this report it is shown that intravenous formulation of isavuconazole could be administered 5/7 days a week in patients who can not swallow capsules, once the steady state has been stably reached and maintained, thanks to its very long half-life. In this case TDM should be highly recommended.
Identifiants
pubmed: 32364049
doi: 10.1080/1120009X.2020.1755591
doi:
Substances chimiques
Antifungal Agents
0
Nitriles
0
Pyridines
0
Triazoles
0
isavuconazole
60UTO373KE
Types de publication
Case Reports
Letter
Langues
eng
Sous-ensembles de citation
IM